The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.
暂无分享,去创建一个
K. Lackey | T. Gilmer | E. Wood | K. Affleck | D. Rusnak | K. Lackey | R. Mullin | B. Keith | K. Alligood | N. Rhodes | W. Knight | D. Murray | K. Glennon | Medicinal Chemistry